The DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index.
Anti‐infective properties of epigallocatechin‐3‐gallate (EGCG), a component of green tea
Open accessAbstract
The consumption of green tea (Camellia sinensis) has been shown to have many physiological and pharmacological health benefits. In the past two decades several studies have reported that epigallocatechin‐3‐gallate (EGCG), the main constituent of green tea, has anti‐infective properties. Antiviral activities of EGCG with different modes of action have been demonstrated on diverse families of viruses, such as R etroviridae, O rthomyxoviridae and F laviviridae and include important human pathogens like human immunodeficiency virus, influenza A virus and the hepatitis C virus. Furthermore, the molecule interferes with the replication cycle of DNA viruses like hepatitis B virus, herpes simplex virus and adenovirus. Most of these studies demonstrated antiviral properties within physiological concentrations of EGCG in vitro. In contrast, the minimum inhibitory concentrations against bacteria were 10–100‐fold higher. Nevertheless, the antibacterial effects of EGCG alone and in combination with different antibiotics have been intensively analysed against a number of bacteria including multidrug‐resistant strains such as methicillin‐resistant S taphylococcus aureus or S tenotrophomonas maltophilia. Furthermore, the catechin EGCG has antifungal activity against human‐pathogenic yeasts like C andida albicans. Although the mechanistic effects of EGCG are not fully understood, there are results indicating that EGCG binds to lipid membranes and affects the folic acid metabolism of bacteria and fungi by inhibiting the cytoplasmic enzyme dihydrofolate reductase. This review summarizes the current knowledge and future perspectives on the antibacterial, antifungal and antiviral effects of the green tea constituent EGCG.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pappas, P. G., Kauffman, C. A., Andes, D., Benjamin, D. K., Calandra, T. F., Edwards, J. E., Filler, S. G., Fisher, J. F., Kullberg, B.-J., Zeichner, L. O., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/596757 · Cited by 3,191
Cosgrove, S. E., Sakoulas, G., Perencevich, E. N., Schwaber, M. J., Karchmer, A. W., & Carmeli, Y. (2003) · Clinical Infectious Diseases · doi:10.1086/345476 · Cited by 1,964
Beneficial Effects of Green Tea—A Review
Cabrera, C., Artacho, R., & Giménez, R. (2006) · Journal of the American College of Nutrition · doi:10.1080/07315724.2006.10719518 · Cited by 1,904
Stenotrophomonas maltophilia: an Emerging Global Opportunistic Pathogen
Brooke, J. S. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.00019-11 · Cited by 1,434
Evolving epidemiology of hepatitis C virus
Lavanchy, D. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03432.x · Cited by 1,318
Hepatitis B Virus Infection: Epidemiology and Vaccination
Shepard, C. W. (2006) · Epidemiologic Reviews · doi:10.1093/epirev/mxj009 · Cited by 1,148
Epidemic Profile of Shiga-Toxin–Producing Escherichia coli O104:H4 Outbreak in Germany
Frank, C., Werber, D., Cramer, J. P., Askar, M., Faber, M., an der Heiden, M., Bernard, H., Fruth, A., Prager, R., Spode, A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1106483 · Cited by 1,139
The Role of Tea in Human Health: An Update
McKay, D. L., & Blumberg, J. B. (2002) · Journal of the American College of Nutrition · doi:10.1080/07315724.2002.10719187 · Cited by 772
HIV/AIDS epidemiology, pathogenesis, prevention, and treatment
Simon, V., Ho, D. D., & Abdool Karim, Q. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69157-5 · Cited by 730
Lee, M., Maliakal, P. P., Chen, L., Meng, X., Bondoc, F. Y., Prabhu, S., Lambert, G. H., Mohr, S. N., & Yang, C. S. (2002) · PubMed · Cited by 720
Chow, H.-H. S., Cai, Y., Hakim, I. A., Crowell, J. A., Shahi, F., Brooks, C. A., Dorr, R. T., Hara, Y., & Alberts, D. S. (2003) · PubMed · Cited by 706
Aiken, C., Konner, J., Landau, N. R., Lenburg, M. E., & Trono, D. (1994) · Cell · doi:10.1016/0092-8674(94)90360-3 · Cited by 695
Parczewska, O. K., Posaconazol, przeciwgrzybicze, L., Anidulafungina, Micafungina, & wrażliwość, O. (2009) · Cited by 656
Antiviral effect of catechins in green tea on influenza virus
Song, J.-M., Lee, K.-H., & Seong, B.-L. (2005) · Antiviral Research · doi:10.1016/j.antiviral.2005.06.010 · Cited by 654
Bactericidal catechins damage the lipid bilayer
Ikigai, H., Nakae, T., Hara, Y., & Shimamura, T. (1993) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(93)90323-r · Cited by 644
Tackling Human Fungal Infections
Brown, G. D., Denning, D. W., & Levitz, S. M. (2012) · Science · doi:10.1126/science.1222236 · Cited by 619
Antimicrobial Activity of 10 Different Plant Polyphenols against Bacteria Causing Food-Borne Disease
Taguri, T., Tanaka, T., & Kouno, I. (2004) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.27.1965 · Cited by 474
Zhao, W.-H., Hu, Z.-Q., Okubo, S., Hara, Y., & Shimamura, T. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.6.1737-1742.2001 · Cited by 395
Timpe, J. M., Stamataki, Z., Jennings, A., Hu, K., Farquhar, M. J., Harris, H. J., Schwarz, A., Desombere, I., Roels, G. L., Balfe, P., et al. (2008) · Hepatology · doi:10.1002/hep.21959 · Cited by 389
Inhibition of the infectivity of influenza virus by tea polyphenols
Nakayama, M., Suzuki, K., Toda, M., Okubo, S., Hara, Y., & Shimamura, T. (1993) · Antiviral Research · doi:10.1016/0166-3542(93)90008-7 · Cited by 385
Antimicrobial properties of green tea catechins
Taylor, P. W., Hamilton-Miller, J. M. T., & Stapleton, P. D. (2005) · Food Science <html_ent glyph="@amp;" ascii="&"/> Technology Bulletin: Functional Foods · doi:10.1616/1476-2137.14184 · Cited by 373
The complex oral microflora of high‐risk individuals and groups and its role in the caries process
Beighton, D. (2005) · Community Dentistry and Oral Epidemiology · doi:10.1111/j.1600-0528.2005.00232.x · Cited by 360
The green tea polyphenol, epigallocatechin-3-gallate, inhibits hepatitis C virus entry
Ciesek, S., von Hahn, T., Colpitts, C. C., Schang, L. M., Friesland, M., Steinmann, J., Manns, M. P., Ott, M., Wedemeyer, H., Meuleman, P., et al. (2010) · Hepatology · doi:10.1002/hep.24610 · Cited by 303
Self-citationA Single Ascending Dose Study of Epigallocatechin Gallate in Healthy Volunteers
Ullmann, U., Haller, J., Decourt, J., Girault, N., Girault, J., Richard-Caudron, A., Pineau, B., & Weber, P. (2003) · Journal of International Medical Research · doi:10.1177/147323000303100205 · Cited by 298
Role of Hydrogen Peroxide in Bactericidal Action of Catechin
Arakawa, H., Maeda, M., Okubo, S., & Shimamura, T. (2004) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.27.277 · Cited by 292
(−)-Epigallocatechin- 3 -gallate is a new inhibitor of hepatitis C virus entry
Calland, N., Albecka, A., Belouzard, S., Wychowski, C., Duverlie, G., Descamps, V., Hober, D., Dubuisson, J., Rouillé, Y., & Séron, K. (2012) · Hepatology · doi:10.1002/hep.24803 · Cited by 279
Sudano Roccaro, A., Blanco, A. R., Giuliano, F., Rusciano, D., & Enea, V. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.6.1968-1973.2004 · Cited by 263
Hirasawa, M. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh046 · Cited by 260
Wang, R., Zhou, W., & Jiang, X. (2008) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf0730338 · Cited by 257
Modulation of β-lactam resistance in Staphylococcus aureus by catechins and gallates
Stapleton, P. D., Shah, S., Anderson, J. C., Hara, Y., Hamilton-Miller, J. M. T., & Taylor, P. W. (2004) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2003.09.027 · Cited by 252
Induction and evasion of type I interferon responses by influenza viruses
García-Sastre, A. (2011) · Virus Research · doi:10.1016/j.virusres.2011.10.017 · Cited by 234
Different susceptibilities of Staphylococcus and Gram-negative rods to epigallocatechin gallate
Yoda, Y., Hu, Z.-Q., Shimamura, T., & Zhao, W.-H. (2004) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-003-0284-0 · Cited by 231
In Vitro and In Vivo Activities of Tea Catechins against Helicobacter pylori
Mabe, K., Yamada, M., Oguni, I., & Takahashi, T. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.7.1788 · Cited by 229
Yamaguchi, K., Honda, M., Ikigai, H., Hara, Y., & Shimamura, T. (2002) · Antiviral Research · doi:10.1016/s0166-3542(01)00189-9 · Cited by 225
Inhibition of adenovirus infection and adenain by green tea catechins
Weber, J. M., Ruzindana-Umunyana, A., Imbeault, L., & Sircar, S. (2003) · Antiviral Research · doi:10.1016/s0166-3542(02)00212-7 · Cited by 225
Cui, Y., Oh, Y. J., Lim, J., Youn, M., Lee, I., Pak, H. K., Park, W., Jo, W., & Park, S. (2012) · Food Microbiology · doi:10.1016/j.fm.2011.08.019 · Cited by 220
Williamson, M. P., McCormick, T. G., Nance, C. L., & Shearer, W. T. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.08.016 · Cited by 195
CD81 is dispensable for hepatitis C virus cell-to-cell transmission in hepatoma cells
Witteveldt, J., Evans, M. J., Bitzegeio, J., Koutsoudakis, G., Owsianka, A. M., Angus, A. G. N., Keck, Z.-Y., Foung, S. K. H., Pietschmann, T., Rice, C. M., et al. (2009) · Journal of General Virology · doi:10.1099/vir.0.006700-0 · Cited by 190
Self-citationAntimicrobial Activities of Tea Catechins and Theaflavins and Tea Extracts against Bacillus cereus
Friedman, M., Henika, P. R., Levin, C. E., Mandrell, R. E., & Kozukue, N. (2006) · Journal of Food Protection · doi:10.4315/0362-028x-69.2.354 · Cited by 187
Epigallocatechin Gallate Inactivates Clinical Isolates of Herpes Simplex Virus
Isaacs, C. E., Wen, G. Y., Xu, W., Jia, J. H., Rohan, L., Corbo, C., Di Maggio, V., Jenkins, E. C., & Hillier, S. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00825-07 · Cited by 183
Sirk, T. W., Brown, E. F., Sum, A. K., & Friedman, M. (2008) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf8013298 · Cited by 179
Lambert, J. D., Sang, S., Hong, J., Kwon, S.-J., Lee, M.-J., Ho, C.-T., & Yang, C. S. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.011460 · Cited by 165
Zhao, W., Hu, Z., Hara, Y., & Shimamura, T. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.7.2266-2268.2002 · Cited by 157
Yam, T., Hamilton-Miller, J. M., & Shah, S. S. (1998) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/42.2.211 · Cited by 153
Hauber, I., Hohenberg, H., Holstermann, B., HUNSTEIN, W., & Hauber, J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811827106 · Cited by 150
Kawai, K., Tsuno, N. H., Kitayama, J., et al. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(03)02007-4 · Cited by 146
Gordon, N. C., & Wareham, D. W. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2010.03.025 · Cited by 139
Epigallocatechin Gallate Inhibits Biofilm Formation by Ocular Staphylococcal Isolates
Blanco, A. R., Roccaro, A. S., Spoto, C. G., Nostro, A., & Rusciano, D. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.10.4339-4343.2005 · Cited by 136
Vaccine production capacity for seasonal and pandemic (H1N1) 2009 influenza
Collin, N., & de Radiguès, X. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.06.034 · Cited by 131
Additional Inhibitory Effect of Tea Extract on the Growth of Influenza A and B Viruses in MDCK Cells
Imanishi, N., Tuji, Y., Katada, Y., et al. (2002) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2002.tb02724.x · Cited by 128
Antibacterial and bactericidal activities of Japanese green tea.
Masako, T. O. D. A., Okubo, S., Ohnishi, R., & Shimamura, T. (1989) · Nippon Saikingaku Zasshi · doi:10.3412/jsb.44.669 · Cited by 126
Evensen, N. A., & Braun, P. C. (2009) · Canadian Journal of Microbiology · doi:10.1139/w09-058 · Cited by 123
Preclinical development of the green tea catechin, epigallocatechin gallate, as an HIV-1 therapy
Nance, C. L., Siwak, E. B., & Shearer, W. T. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.12.024 · Cited by 118
Inhibition of Epstein–Barr virus lytic cycle by (−)-epigallocatechin gallate
Chang, L.-K., Wei, T.-T., Chiu, Y., et al. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00067-6 · Cited by 117
THE EPIDEMIOLOGY OF BACTERIAL SEPSIS
Rangel-Frausto, M. S. (1999) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(05)70076-3 · Cited by 110
Epigallocatechin Gallate Inhibits the HIV Reverse Transcription Step
Li, S., Hattori, T., & Kodama, E. N. (2011) · Antiviral chemistry & chemotherapy · doi:10.3851/imp1774 · Cited by 110
Zhou, T., Guo, H., Guo, J., Cuconati, A., Mehta, A. S., & Block, T. M. (2006) · Antiviral Research · doi:10.1016/j.antiviral.2006.05.006 · Cited by 109
Xu, J. C., Wang, J., Dèng, F., et al. (2008) · Antiviral Research · doi:10.1016/j.antiviral.2007.11.011 · Cited by 106
(−)-Epigallocatechin-3-gallate inhibits the replication cycle of hepatitis C virus
Chen, C., Qiu, H., Gong, J., et al. (2012) · Archives of Virology · doi:10.1007/s00705-012-1304-0 · Cited by 105
Green tea inhibits Helicobacter growth in vivo and in vitro
Stoicov, C., Saffari, R., & Houghton, J. (2009) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2008.10.032 · Cited by 104
Antifolate Activity of Epigallocatechin Gallate against Stenotrophomonas maltophilia
Navarro-Martínez, M. D., Navarro-Perán, E., Cabezas‐Herrera, J., Ruiz-Gómez, J., Garcı́a-Cánovas, F., & Rodríguez‐López, J. N. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.7.2914-2920.2005 · Cited by 101
Antibacterial and Antifungal Activities of New Acylated Derivatives of Epigallocatechin Gallate
Matsumoto, Y., Kaihatsu, K., Nishino, K., Ogawa, M., Kato, N., & Yamaguchi, A. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00053 · Cited by 95
Antiviral therapy and resistance with hepatitis B virus infection
Tillmann, H. L. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i1.125 · Cited by 92
Mori, S., Miyake, S., Kobe, T., Nakaya, T., Fuller, S. D., Kato, N., & Kaihatsu, K. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.02.020 · Cited by 91
Yamada, H., Takuma, N., Daimon, T., & Hara, Y. (2006) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2006.12.669 · Cited by 91
Navarro-Martínez, M. D., García-Cánovas, F., & Rodríguez-López, J. N. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl124 · Cited by 91
Epigallocatechin gallate inhibits HBV DNA synthesis in a viral replication - inducible cell line
He, W. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i11.1507 · Cited by 84
Dynamic Behavior of Tea Catechins Interacting with Lipid Membranes As Determined by NMR Spectroscopy
Uekusa, Y., Kamihira, M., & Nakayama, T. (2007) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf0712402 · Cited by 80
Osterburg, A. R., Gardner, J., Hyon, S., Neely, A., & Babcock, G. F. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.02710.x · Cited by 75
Digallate Dimers of (−)-Epigallocatechin Gallate Inactivate Herpes Simplex Virus
Isaacs, C. E., Xu, W., Merz, G., Hillier, S. L., Rohan, L. C., & Wen, G. Y. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05531-11 · Cited by 75
Antifungal and fungicidal activities of tea extract and catechin against Trichophyton.
OKUBO, S., Masako, T. O. D. A., Yukihiko, H. A. R. A., & Shimamura, T. (1991) · Nippon Saikingaku Zasshi · doi:10.3412/jsb.46.509 · Cited by 73
Takabayashi, F., Harada, N., Yamada, M., et al. (2004) · Journal of Gastroenterology · doi:10.1007/s00535-003-1246-0 · Cited by 71
Is green tea good for HIV-1 infection?
Nance, C. L., & Shearer, W. T. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2003.08.048 · Cited by 65
Park, B. J., Park, J., Taguchi, H., Fukushima, K., Hyon, S.-H., & Takatori, K. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.06.037 · Cited by 62
Matsunaga, K., Klein, T., Friedman, H. P., & Yamamoto, Y. (2001) · Infection and Immunity · doi:10.1128/iai.69.6.3947-3953.2001 · Cited by 61
Kajiya, K., Kumazawa, S., Naito, A., & Nakayama, T. (2007) · Magnetic Resonance in Chemistry · doi:10.1002/mrc.2157 · Cited by 50
The evaluation of catechins that contain a galloyl moiety as potential HIV-1 integrase inhibitors
Jiang, F., Chen, W., Yi, K., Wu, Z., Si, Y., Han, W., & Zhao, Y. (2010) · Clinical Immunology · doi:10.1016/j.clim.2010.08.007 · Cited by 48
Epstein-Barr Virus, Cytomegalovirus, and Infectious Mononucleosis
Bravender, T. D. (2005) · American Academy of Pediatrics eBooks · doi:10.1542/9781581105636-epstein-barr · Cited by 48
Han, Y. (2007) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.30.1693 · Cited by 44
Mechanism of inhibition of wt‐dihydrofolate reductase from E. coli by tea epigallocatechin‐gallate
Spina, M., Cuccioloni, M., Mozzicafreddo, M., Montecchia, F., Pucciarelli, S., Eleuteri, A. M., Fioretti, E., & Angeletti, M. (2008) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.21914 · Cited by 43
Isogai, E., Isogai, H., Takeshi, K., & Nishikawa, T. (1998) · Microbiology and Immunology · doi:10.1111/j.1348-0421.1998.tb02260.x · Cited by 38
Bikels-Goshen, T., Landau, E., Saguy, I. S., & Shapira, R. (2010) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2010.01.011 · Cited by 36
Li, L., Stillemark-Billton, P., Adiels, C. B., Boström, P., Andersson, L. K., Rutberg, M., Ericsson, J., Magnusson, B., Marchesan, D., Ljungberg, A., et al. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m500424-jlr200 · Cited by 32
Park, B. J., Taguchi, H., Kamei, K., Matsuzawa, T., Hyon, S.-H., & Park, J. (2011) · Yonsei Medical Journal · doi:10.3349/ymj.2011.52.3.535 · Cited by 32
Effect of Catechin on the Ultrastructure of Trichophyton mentagrophytes
Toyoshima, Y., Okubo, S., Masako, T. O. D. A., Hara, Y., & Shimamura, T. (1994) · Kansenshogaku zasshi · doi:10.11150/kansenshogakuzasshi1970.68.295 · Cited by 31
Lee, M., Maliakal, P. P., Chen, L., Meng, X., Bondoc, F. Y., Prabhu, S., Lambert, G. H., Mohr, S. N., & Yang, C. S. (2002) · Cancer Epidemiology and Prevention Biomarkers · Cited by 28
Nakane, H., & Ono, K. (1989) · PubMed · Cited by 26
Cited by
Rudrapal, M., Khairnar, S. J., Khan, J., Dukhyil, A. B., Ansari, M. A., Alomary, M. N., Alshabrmi, F. M., Palai, S., Deb, P. K., & Devi, R. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.806470 · Cited by 1,084
Anti-infective Properties of the Golden Spice Curcumin
Praditya, D., Kirchhoff, L., Brüning, J., Rachmawati, H., Steinmann, J., & Steinmann, E. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00912 · Cited by 373
Self-citationAntibiotic resistance breakers: can repurposed drugs fill the antibiotic discovery void?
Brown, D. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4675 · Cited by 359
Roles of flavonoids against coronavirus infection
Russo, M., Moccia, S., Spagnuolo, C., Tedesco, I., & Russo, G. L. (2020) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2020.109211 · Cited by 323
Fürst, R., & Zündorf, I. (2014) · Mediators of Inflammation · doi:10.1155/2014/146832 · Cited by 269
Metadata
- Authors
- Steinmann, J., Buer, J., Pietschmann, T., & Steinmann, E.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2013-02-20
- Volume
- 168
- Issue
- 5
- Pages
- 1059-1073
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W1686797737
- Cited by
- 559
- References
- 87
- FWCI
- 13.72
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.